My Blog List

Mylan Health Hackathon to Focus on Delivering Better Health for a Better World

BENGALURU, India, and PITTSBURGH – March 8, 2016 – Mylan N.V. (NASDAQ, TASE: MYL) today announced that the company will host a health hackathon at its Global Center in Bengaluru on March 19-20, 2016.
                
The event will focus on Better Health for a Better World.  Participants in the hackathon will be creating innovative solutions for patients, payers, providers and other healthcare professionals. Mylan conducted a similar event last month at its Global Center near Pittsburgh.


Hackathon teams will build solutions to answer a variety of healthcare challenges, such as overcoming obstacles to HIV treatment in emerging markets, leveraging existing technology to increase Indians’ access to healthcare, and accessing public datasets and application programming interfaces to build insights about diseases.


Mylan President Rajiv Malik said, “As a company committed to setting new standards in healthcare, we are excited to host hackathons that can help launch a new generation of solutions capable of delivering better health for a better world. In addition, we look forward to welcoming hackathon participants to our new Global Center in Bengaluru, which we opened in 2015 to help support Mylan’s extensive and growing presence in India. The country currently is home to nearly half of our workforce and more than half of our manufacturing facilities.”


The hackathon is open to professionals and students attending engineering colleges and healthcare institutes. Registration is required. Visit http://mylanapps.com/hacksummit/bengaluru.aspx to learn more and register.


About Mylan

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,400 generic and branded pharmaceuticals, including antiretroviral therapies on which nearly 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in approximately 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world’s largest producers of active pharmaceutical ingredients. Every member of our more than 35,000 strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at mylan.com
Theme images by chuwy. Powered by Blogger.